Effects of different concentrations of poly(vinyl pyrrolidone) on the solubility of lamotrigine and diazepam in ethanol + water mixtures at 298.2 K

Journal of Chemical and Engineering Data

Volumn 55, Issue 1, 2010, Pages 570-573

  Soltanpour, Shahla ^a   Acree Jr , William E ^b   Jouyban, Abolghasem ^c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TABRIZ   (Iran)

^c UNIVERSITY OF NORTH TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONCENTRATION OF; GENERAL VERSION; JOUYBAN-ACREE MODEL; LAMOTRIGINE; POLY(VINYL PYRROLIDONE); RELATIVE DEVIATIONS; SOLUBILITY DATA; WATER MIXTURE;

ETHANOL; SOLUBILITY;

TERNARY SYSTEMS;

EID: 75449107779     PISSN: 00219568     EISSN: None     Source Type: Journal    
DOI: 10.1021/je900369w     Document Type: Article

References (26)

1. Dressman, J.; Reppas, C. Drug Solubility: How to Measure it, How to Improve it. Adv. Drug Delivery Rev. 2007, 59, 531-532.
2. Serajuddin, A. T. M. Salt Formation to Improve Drug Solubility. Adv. Drug Delivery Rev. 2007, 59, 603-616.
3. Blagden, N.; de Matas, M.; Gavan, P. T.; York, P. Crystal Engineering of Active Pharmaceutical Ingredients to Improve Solubility and Dissolution Rates. Adv. Drug Delivery Rev. 2007, 59, 617-630.
4. Brewster, M. E.; Loftsson, T. Cyclodextrins as Pharmaceutical Solubilizers. Adv. Drug Delivery Rev. 2007, 59, 645-666.
5. Hauss, D. J. Oral Lipid-Based Formulations. Adv. Drug Delivery Rev. 2007, 59, 667-676.
6. Stella, V. J.; Nti-Addae, K. W. Prodrug Strategies to Overcome Poor Water Solubility. Adv. Drug Delivery Rev. 2007, 59, 677-694.
7. Marsac, P. J.; Li, T.; Taylor, L. S. Estimation of Drug-Polymer Miscibility and Solubility in Amorphous Solid Dispersions Using Experimentally Determined Interaction Parameters. Pharm. Res. 2009, 26, 1-13.
8. Ribeiro, L.; Viga, F. Complexation of Vinpocetine with Cyclodextrins in the Presence or Absence of Polymers. Binary and Ternary Complexes Preparation and Characterization. J. Inclusion Phenom. Macrocyclic Chem. 2002, 44, 251-256.
9. Haznedar, S.; Dortuņc, B. Preparation and in Vitro Evaluation of Eudragit Microspheres Containing Acetazolamide. Int. J. Pharm. 2004, 269, 131-140.
10. Verdun, C.; Couvreur, P.; Vranckx, H.; Lenaerts, V.; Roland, M. Development of a Nanoparticle Controlled-Release Formulation for Human Use. J. Controlled Release 1986, 3, 205-510.
11. Shinkai, N.; Korenaga, K.; Mizu, H.; Yamauchi, H. Intra-Articular Penetration of Ketoprofen and Analgesic Effects after Topical Patch Application in Rats. J. Controlled Release 2008, 131, 107-112.
12. Chono, S.; Li, S. D.; Conwell, C. C.; Huang, L. An Efficient and Low Immunostimulatory Nanoparticle Formulation for Systemic siRNA Delivery to the Tumor. J. Controlled Release 2008, 131, 64-69.
13. Oren, P. L.; Seidler, W. M. K. Sustained Release Matrix. U.S. Patent 4, 968, 508, November 6, 1990.
14. Streubel, A.; Siepmann, J.; Dashevsky, A.; Bodmeier, R. pHindependent Release of a Weakly Basic Drug from Water-Insoluble and -Soluble Matrix Tablets. J. Controlled Release 2000, 67, 101-110.
15. Timmins, P.; Delargy, A. M.; Howard, J. R. Optimization and Characterization of a pH-Independent Extended-Release Hydrophilic Matrix Tablet. Pharm. DeV. Technol. 1997, 2, 25-31.
16. McHugh, A. J.; Desnoyer, J. R.; Raman, C. Injectable Drug Delivery Based on Polymer Solutions: Experiment and Modeling. ACS Symp. Ser. 2008, 924, 14-28.
17. Jouyban, A. Review of the Cosolvency Models for Predicting Solubility of Drugs in Water-Cosolvent Mixtures. J. Pharm. Pharm. Sci. 2008, 11, 32-58.
18. Shayanfar, A.; Fakhree, M. A. A.; Acree Jr, W. E.; Jouyban, A. Solubility of Lamotrigine, Diazepam, and Clonazepam in Ethanol + Water Mixtures at 298.15 K. J. Chem. Eng. Data 2009, 54, 1107-1109.
19. Moffat, A. C. Clarke's Analysis of Drug and Poisons; Pharmaceutical Press: London, 2004.
20. Loftsson, T.; Hreinsdoìttir, D. Determination of Aqueous Solubility by Heating and Equilibration: A Technical Note. AAPS Pharm. Sci. Tech. 2006, 7, e1-e4.
21. Florey, K. Analytical Profiles of Drug Substances; Academic Press: New York, 1977; Vol. 6, p 70.
22. LlinaÌs, A.; Glen, R. C.; Goodman, J. M. Solubility Challenge: Can You Predict Solubilities of 32 Molecules Using a Database of 100 Reliable Measurements? J. Chem. Inf. Model 2008, 48, 1289-1303.
23. Mura, P.; Faucci, M. T.; Bettinetti, G. P. The Influence of Polyvinylpyrrolidone on Naproxen Complexation with Hydroxypropyl-β- cyclodextrin. Eur. J. Pharm. Sci. 2001, 13, 187-194.
24. Laitinen, R.; Suihko, E.; Toukola, K.; Bjorkqvist, M.; Riikonen, J.; Lehto, V. P.; Jarvinen, K.; Ketolainen, J. Intraorally Fast-Dissolving Particles of a Poorly Soluble Drug: Preparation and in Vitro Characterization. Eur. J. Pharm. Biopharm 2009, 71, 271-281.
25. Chowdary, K. P. R.; Srinivas, S. V. Influence of Hydrophilic Polymers on Celecoxib Complexation with Hydroxypropyl-β-cyclodextrin. AAPS Pharm. Sci. Tech. 2006, 7, E1-E6.
26. Liu, C.; Desai, K. G. H.; Liu, C. Solubility of Rofecoxib in the Presence of Mannitol, Poly(vinylpyrrolidone) K30, Urea, Polyethylene Glycol 4000, and Polyethylene Glycol 6000 at (298.15, 303.15, and 308.15) K. J. Chem. Eng. Data 2005, 50, 661-665.